Cardiac and Gastric Function
Conditions
Brief summary
Acupuncture have been used in clinical treatment of diseases for at least 3,000 years, and the efficacy of acupuncture has been recognized by countries all over the world. However, most of the selected points for acupuncture treatment of diseases are based on ancient books or inheritance of experience. For example, the Shizong Acupoint Ballad of acupuncture records: Neiguan (PC6) care about the chest and stomach, that is, acupuncture Neiguan can be used to treat chest, heart and stomach diseases. However, there is no scientific evidence to verify this argument so far that the Shizong Acupoint Ballad mentions Neiguan care for the chest and stomach, and that means that Neiguan acupoint can treat the diseases of cardiovascular system and gastrointestinal system. The purpose is to verify the argument of Neiguan care about the chest and stomach, and design a clinical trial of the Neiguan and Jianshi (PC5) on both sides of the electroacupuncture (EA) to simultaneously evaluate the heart and stomach functions. We designed a crossover test; total 72 subjects randomly equally divide the into a sham group (sham electroacupuncture) and an EA group \[2Hz EA (PC6 is cathode) and PC5 is anode\]. At least one week of washing time, then the EA group changed to a sham group and the sham group changed to an EA group. In this study, it is expected that the EA at PC6 and PC5 will affect the heart function and the function of the stomach at the same time, verifying the argument that the PC6 care of the chest and stomach recorded in the Shizong Acupoint Ballad.
Interventions
OTHERelectroacupuncture
Electroacupuncture at Neiguan and Jianshi acupoint
Sponsors
China Medical University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* (1) Normal and healthy participants * (2) Male or female * (3) The age range is 20 to 40 years old. * (4) Those who participates and signs informed consent after explaining the research purpose and process in detail.
Exclusion criteria
* (1) Those with serious diseases, such as heart failure, chronic failure or cancer patients, etc. * (2) Those who are allergic to stainless steel needles for acupuncture. * (3) Pregnant or breastfeeding * (4) Those who are taking medicines or food such as coffee, etc. that will affect heart function such as heart rate, or gastric peristalsis. * (5) Unable to cooperate with researchers such as mental instability. * (6) Those who do not sign the consent form.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Gastric Function | thirty minutes. | Evaluation of gastric electrical rhythm with electrogastrography before electroacupuncture interventions. Gastric function (electrogastrography) is first recorded for 30 minutes, and then intervention (electroacupuncture) is implemented, and gastric function is recorded at the same time. |
| Cardiac Function | thirty minutes. | Evaluation of cardiac function with the Osypka non-invasive cardiac output monitor before electroacupuncture interventions . Cardiac function (OSCAR, non-invasive cardiac output meter) is first recorded for 30 minutes, and then intervention (electroacupuncture) is implemented, and cardiac function is recorded at the same time. |
Contacts
Primary ContactChing-Liang Hsieh
Outcome results
None listed